NCT02488044: A trial that was reported late by Aeglea Biotherapeutics
This trial has reported, although it was 1027 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02488044 |
|---|---|
| Title | A Phase 1/2 Open-label Study in Patients With Arginase I Deficiency to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous AEB1102 |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | June 30, 2016 |
| Completion date | Feb. 28, 2019 |
| Required reporting date | Feb. 28, 2020, midnight |
| Actual reporting date | Dec. 21, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 1027 |